P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy-Reference-Cited by-同舟云学术

P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy

Published:2004-04 Issue:4 Volume:48 Page:1073-1081
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Sankatsing Sanjay U. C.¹²,Beijnen Jos H.³,Schinkel Alfred H.⁴,Lange Joep M. A.¹²,Prins Jan M.¹

Affiliation:

1. Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam

2. International Antiviral Therapy Evaluation Center

3. Department of Pharmacy & Pharmacology, Slotervaart Hospital

4. Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.4.1073-1081.2004

Reference154 articles.

1. Alaoui-Jamali, M. A., R. L. Schecter, Y. M. Rustum, M. G. Centurioni, S. Lehnert, and G. Batist. 1993. In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933. J. Pharmacol. Exp. Ther.264:1299-1304.

2. Ameyaw, M. M., F. Regateiro, T. Li, X. Liu, M. Tariq, A. Mobarek, N. Thornton, G. O. Folayan, J. Githang'a, A. Indalo, D. Ofori-Adjei, D. A. Price-Evans, and H. L. McLeod. 2001. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics11:217-221.

3. Andreana, A., S. Aggarwal, S. Gollapudi, D. Wien, T. Tsuruo, and S. Gupta. 1996. Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retrovir.12:1457-1462.

4. Antonelli, G., O. Turriziani, M. Cianfriglia, E. Riva, G. Dong, A. Fattorossi, and F. Dianzani. 1992. Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. AIDS Res. Hum. Retrovir.8:1839-1844.

5. Barry, M., F. Mulcahy, C. Merry, S. Gibbons, and D. Back. 1999. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clin. Pharmacokinet.36:289-304.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring bat-inspired cyclic tryptophan diketopiperazines as ABCB1 Inhibitors;Communications Chemistry;2024-07-13

2. Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy;Journal of Drug Targeting;2024-05-27

3. Discovery and structural optimization of a new series of N-acyl-2-aminobenzothiazole as inhibitors of Zika virus;Bioorganic & Medicinal Chemistry;2023-11

4. In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach;AIMS Microbiology;2023

5. The Role of Pannexin-1 Channels in HIV and NeuroHIV Pathogenesis;Cells;2022-07-20